A large observational study published in Nature Communications (Wang et al., 2024) followed 83,825 patients with obesity and found that GLP-1 receptor agonists, including semaglutide, were associated with a substantially lower risk of alcohol use disorder (AUD) incidence and recurrence
Avoid high-fat meals, large portions, and foods known to cause GI distress independently
Taking Contrave with a GLP-1 medication like Wegovy or Zepbound is not a standard combination and should only be done under close medical supervision
doi:10.1017/S0033291716002841 144
C.Castilla-CortazarI
Additionally, factors like age, genetics, sun damage, and the total amount of weight lost all influence how much excess skin develops